ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Breasthealth Plus

Also known as: Breasthealth Plus, breast health supplements, breast cancer supportive supplements, probiotics for breast health, Lactobacillus species (in Breasthealth Plus)

Overview

Breasthealth Plus is a commercial dietary supplement blend, typically comprising probiotics (e.g., Lactobacillus species), antioxidants, vitamins, and herbal extracts. It is designed to support breast tissue health, immune function, and potentially reduce breast cancer risk or aid recovery, primarily in breast cancer patients and survivors. The formulation aims to improve quality of life, modulate immune response, and potentially reduce inflammation. While the specific proprietary blend lacks extensive independent clinical trials, its individual components, particularly probiotics, have been studied in breast cancer contexts, showing promise in gut microbiota modulation and systemic immunomodulatory effects. The supplement is often marketed as an adjunct to conventional breast cancer treatment.

Benefits

Probiotics, a key component of Breasthealth Plus, have demonstrated several benefits for breast cancer patients and survivors. A systematic review and meta-analysis indicated that probiotic supplementation, especially when combined with prebiotics, can significantly reduce pro-inflammatory cytokines like TNF-α, thereby modulating systemic immunity. This immune modulation contributes to improved quality of life in these patients. Additionally, probiotics have shown potential in countering obesity and dyslipidemia, which are common concerns in breast cancer. Improvements in breast-cancer-associated lymphedema quality of life have also been reported. These benefits are typically observed after 8-10 weeks of consistent supplementation, with statistically significant reductions in inflammatory markers and improvements in quality of life metrics. The strongest evidence supports benefits for breast cancer patients and survivors in immune modulation and quality of life improvements.

How it works

The primary mechanism of action for Breasthealth Plus, particularly its probiotic components, involves the modulation of gut microbiota composition. This modulation leads to systemic immunomodulatory effects throughout the body. Probiotics help reduce pro-inflammatory cytokines, such as TNF-α, which are implicated in inflammation and disease progression. They also interact with the gut-brain axis and contribute to overall systemic inflammation reduction. Furthermore, probiotics can impact metabolic parameters, influencing obesity and lipid profiles. While probiotics act locally in the gut, their beneficial metabolites and immune-modulating effects are systemic, influencing various body systems.

Side effects

Breasthealth Plus, primarily due to its probiotic components, is generally considered safe with a low risk of adverse effects. Common side effects, occurring in over 5% of users, are typically mild gastrointestinal symptoms such as bloating or gas. Uncommon side effects (1-5%) may include rare allergic reactions or intolerance to specific probiotic strains. Extremely rare side effects (less than 1%) could theoretically include bacteremia or sepsis in severely immunocompromised patients, though this is highly infrequent. There are no major known drug interactions, but caution is advised when used alongside immunosuppressive therapies. Contraindications include severe immunodeficiency or critical illness. Breast cancer patients undergoing chemotherapy should consult their healthcare providers before using this supplement.

Dosage

Clinical trials suggest a minimum effective dose for probiotics in Breasthealth Plus formulations is approximately 10^9 colony-forming units (CFU) per day. Optimal dosage ranges from 10^9 to 10^10 CFU daily, often combined with prebiotics like fructooligosaccharides (FOS) for synergistic effects that enhance colonization and efficacy. There is no established maximum safe dose, with doses up to 10^10 CFU/day commonly used safely in trials. For observed benefits, daily supplementation is recommended for at least 8-10 weeks. The supplement is typically available in capsules or powders containing live probiotic strains. Proper storage and handling are crucial to maintain the viability of the bacteria and thus the potency of the product.

FAQs

Is Breasthealth Plus effective for breast cancer prevention?

Current evidence supports potential supportive benefits for breast cancer patients and survivors, but it does not establish efficacy for breast cancer prevention.

Are there safety concerns with Breasthealth Plus?

It is generally safe, with mild gastrointestinal side effects possible. Immunocompromised patients should exercise caution and consult a healthcare provider.

When should Breasthealth Plus be taken?

It should be taken daily and consistently for at least 8-10 weeks to observe benefits.

What results can be expected from taking Breasthealth Plus?

Expected results include improvements in quality of life, immune modulation, and metabolic markers. It is not a substitute for conventional medical therapy.

Is Breasthealth Plus more effective with prebiotics?

Yes, combined probiotic-prebiotic formulations have shown greater benefits in clinical studies, enhancing probiotic efficacy.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC10004677/ – This systematic review and meta-analysis of 8 RCTs found that probiotic supplements, especially with prebiotics, significantly reduced inflammatory markers (TNF-α), improved quality of life, and countered obesity/dyslipidemia in breast cancer patients and survivors. It highlights the immunomodulatory and metabolic benefits of probiotics in this population.
  • https://pubmed.ncbi.nlm.nih.gov/36829557/ – This high-quality systematic review and meta-analysis, including 13 articles and 8 RCTs, concluded that probiotic combinations improve immune markers and quality of life in breast cancer patients and survivors. It also emphasized that the addition of prebiotics enhances these beneficial effects, though long-term data and variability in formulations remain limitations.
  • https://ascopubs.org/doi/10.1200/JCO.21.01171 – This systematic review with meta-analysis on eHealth interventions for breast cancer patients showed mixed results for lifestyle and nutrition interventions. While not specific to Breasthealth Plus, it provides indirect context on the challenges and varied outcomes of supportive interventions in this patient group, noting no significant BMI or nutrition improvement in some studies.